KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Current Deferred Revenue: 2019-2024

Historic Current Deferred Revenue for Ginkgo Bioworks Holdings (DNA) over the last 6 years, with Dec 2024 value amounting to $126.5 million.

  • Ginkgo Bioworks Holdings' Current Deferred Revenue rose 10.23% to $25.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.2 million, marking a year-over-year increase of 10.23%. This contributed to the annual value of $126.5 million for FY2024, which is 37.53% down from last year.
  • Per Ginkgo Bioworks Holdings' latest filing, its Current Deferred Revenue stood at $126.5 million for FY2024, which was down 37.53% from $202.5 million recorded in FY2023.
  • Over the past 5 years, Ginkgo Bioworks Holdings' Current Deferred Revenue peaked at $222.6 million during FY2022, and registered a low of $200,000 during FY2020.
  • For the 3-year period, Ginkgo Bioworks Holdings' Current Deferred Revenue averaged around $183.9 million, with its median value being $202.5 million (2023).
  • In the last 5 years, Ginkgo Bioworks Holdings' Current Deferred Revenue soared by 94,500.00% in 2021 and then crashed by 37.53% in 2024.
  • Yearly analysis of 5 years shows Ginkgo Bioworks Holdings' Current Deferred Revenue stood at $200,000 in 2020, then skyrocketed by 94,500.00% to $189.2 million in 2021, then rose by 17.65% to $222.6 million in 2022, then fell by 9.03% to $202.5 million in 2023, then tumbled by 37.53% to $126.5 million in 2024.